Abbott Faces Wrongful Death Lawsuit Over FreeStyle Libre 3 Glucose Monitor Defects
Event summary
- McCune Law Group filed a wrongful death lawsuit against Abbott Diabetes Care Inc. and Abbott Laboratories over alleged defects in FreeStyle Libre 3 glucose monitors, linked to seven global deaths.
- The lawsuit stems from the November 17, 2025, death of Michael Leroy Ford, who died after relying on a falsely low glucose reading from the device.
- Abbott recalled approximately 3 million FreeStyle Libre 3 and Libre 3 Plus sensors in the U.S. due to a manufacturing defect causing inaccurate readings.
- This is the second accuracy-related recall for Abbott's glucose monitors within 18 months, with the FDA classifying both as serious safety concerns.
The big picture
This lawsuit highlights the critical importance of accuracy in medical devices, particularly those used for life-threatening conditions like diabetes. The recurrence of accuracy issues within a short period raises questions about Abbott's quality control processes and could signal broader challenges in the continuous glucose monitoring market. With approximately 3 million devices recalled, the financial and reputational impact on Abbott is substantial.
What we're watching
- Regulatory Scrutiny
- How the FDA's classification of this as a serious medical device safety concern will impact Abbott's regulatory standing and future product approvals.
- Legal Exposure
- Whether additional wrongful death lawsuits or injury claims emerge, potentially leading to significant financial liabilities for Abbott.
- Market Confidence
- The pace at which consumer and healthcare provider trust in Abbott's glucose monitoring products may be restored following these incidents.
Our editorial coverage: